SMStefan Marlovits

Stefan Marlovits

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stefan Marlovits has a total of 387 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Definition of pertinent parameters for the evaluation of articular cartilage repair tissue with high-resolution magnetic resonance imaging

    by Stefan Marlovits, Gabriele Striessnig, Christoph T. Resinger, Silke M. Aldrian, Vilmos Vecsei, Herwig Imhof, Siegfried Trattnig


  • Early postoperative adherence of matrix‐induced autologous chondrocyte implantation for the treatment of full‐thickness cartilage defects of the femoral condyle

    by Stefan Marlovits, Gabriele Striessnig, Florian Kutscha‐Lissberg, Christoph Resinger, Silke M. Aldrian, Vilmos Vécsei, Siegfried Trattnig

    Matrix‐induced autologous chondrocyte implantation (MACI) is a tissue‐engineering technique for the treatment of full‐thickness articular cartilage defects and requires the use of a three‐dimensional collagen type I–III membrane seeded with cultured autologous chondrocytes. The cell‐scaffold construct is implanted in the debrided cartilage defect and fixed only with fibrin glue, with no periosteal cover or further surgical fixation. In a clinical pilot study, the MACI technique was used for the treatment of full‐thickness, weight‐bearing chondral defects of the femoral condyle in 16 patients. All patients were followed prospectively and the early postoperative attachment rate, 34.7 days (range: 22–47) after the scaffold implantation, was determined. With the use of high‐resolution magnetic resonance imaging (MRI), the transplant was graded as completely attached, partially attached, or detached. In 14 of 16 patients (87.5%), a completely‐attached graft was found, and the cartilage defect site was totally covered by the implanted scaffold and repair tissue. In one patient (6.25%), a partial attachment occurred with partial filling of the chondral defect. A complete detachment of the graft was found in one patient (6.25%), which resulted in an empty defect site with exposure of the subchondral bone. Interobserver variability for the MRI grading of the transplants showed substantial agreement (κ=0.775) and perfect agreement (κw=0.99). In conclusion, the implantation and fixation of a cell‐scaffold construct in a deep cartilage defect of the femoral condyle with fibrin glue and with no further surgical fixation leads to a high attachment rate 34.7 days after the implantation, as determined with high resolution MRI.


  • Autologe Chondrozytentransplantation zur Behandlung von Knorpeldefekten des Kniegelenks

    by S. Marlovits, F. Kutscha-Lissberg, S. Aldrian, C. Resinger, P. Singer, P. Zeller, V. Vécsei


  • A new simplified technique for producing platelet-rich plasma: a short technical note

    by S. Marlovits, M. Mousavi, C. Gäbler, J. Erdös, V. Vécsei

    A possible strategy to promote the wound-healing cascade in both soft and hard tissues is the preparation of an autologous platelet-rich plasma (PRP) to encourage the release of growth factors from activated platelets. In this process, PRP combines the advantage of an autologous fibrin clot that will aid in hemostasis as well as provide growth factors in high concentrations to the site of a tissue defect. The PRP preparation can be used as a biological enhancer in the healing of fractures and lumbar fusions. The local application of growth factors seems to promote initiation and early maturation of bone formation. Autologous bone or bone substitutes can be added to this mixture to increase the volume of grafting material. A simplified technique utilizing a commercially available separation system (GPS—Gravitational Platelet Separation System) is described. This system provides a less costly alternative to other previously described augmentation techniques and also presents a patient-friendly and operator-safe alternative. Further experimental studies of the actual concentrations of the growth factors in the PRP samples are necessary in order to validate the platelet concentration and growth-factor activation by laboratory evidence. In further prospective clinical trials, the safety and efficacy of PRP, in combination with autologous bone or bone graft substitutes, must be evaluated.


  • Quantitative analysis of gene expression in human articular chondrocytes in monolayer culture

    by Stefan Marlovits, Matthias Hombauer, Dietmar Tamandl, Vilmos Vècsei, Werner Schlegel

    Human articular chondrocytes (HACs) were isolated from cartilage samples of normal joints and cultivated in monolayer for 56 days. Collagen type I, II, IX, aggrecan, and versican expression was quantified by real-time polymerase chain reaction (PCR). The expression of the genes was highly time-dependent and changed over the culture time. Collagen type I was not present at the beginning of the culture and increased 100-fold during the culture time. Collagen type II and IX expression was found during the entire culture period and decreased more than 100-fold. Aggrecan expression was downregulated 100-fold whereas versican expression increased 10 times. Indices of cell differentiation, defined as ratios of collagen type II to I (CII/I), collagen type IX to I (CIX/I), and aggrecan to versican (Agg/Ver), were significantly higher at the beginning of the culture and decreased over the culture period. The CII/I and CIX/I ratios formed three phases, with a plateau at the beginning, followed by a transition phase and a steady state at the end of the culture time, whereas the Agg/Ver ratio declined constantly. The accurate quantitative assessment of extracellular matrix gene expression in samples of chondrocytes taken from monolayer culture can be used to monitor chondrocyte metabolism as well as changes in the cell differentiation status.


  • Osteochondritis dissecans of the knee

    by S. Marlovits, P. Singer, C. Resinger, S. Aldrian, F. Kutscha-Lissberg, V. Vécsei

  • Collagen Expression in Tissue Engineered Cartilage of Aged Human Articular Chondrocytes in a Rotating Bioreactor

    by S. Marlovits, B. Tichy, M. Truppe, D. Gruber, W. Schlegel

    This study describes the culture and three-dimensional assembly of aged human articular chondrocytes under controlled oxygenation and low shear stress in a rotating-wall vessel. Chondrocytes cultured in monolayer were released and placed without any scaffold as a single cell suspension in a rotating bioreactor for 12 weeks. Samples were analyzed with immunohistochemistry, molecular biology and electron microscopy. During serial monolayer cultures chondrocytes dedifferentiated to a “fibroblast-like” structure and produced predominantly collagen type I. When these dedifferentiated cells were transferred to the rotating bioreactor, the cells showed a spontaneous aggregation and formation of solid tissue during the culture time. Expression of collagen type II and other components critical for the extracellular cartilage matrix could be detected. Transmission electron microscopy revealed a fine network of randomly distributed collagen fibrils. This rotating bioreactor proves to be a useful tool for providing an environment that enables dedifferentiated chondrocytes to redifferentiate and produce a cartilage-specific extracellular matrix.


  • Zelluläre, molekularbiologische und morphologische Untersuchungen zur autologen Chondrozytentransplantation (ACT)

    by S. Marlovits, Michaela Truppe, W. Schlegel, V. Vécsei, M. Schnabel

    Zur Behandlung umschriebener Defekte des artikulären Gelenkknorpels wird die autologe Chondrozytentransplantation (ACT) zunehmend als neue biologische Methode der Knorpelreparatur empfohlen. Die unterschiedlichen Ergebnisse aus der Grundlagenforschung, den tierexperimentellen Untersuchungen und den klinischen Studien lassen derzeit eine abschließende Bewertung der Wirksamkeit dieser Methode nicht zu. In der Zellkultur zeigen Knorpelzellen innerhalb kurzer Zeit deutliche morphologische Veränderungen, mit dem Auftreten fibroblastenähnlicher Zellformen, und den Verlust der Synthese knorpelspezifischer Kollagentypen. Die molekularbiologischen Untersuchungen bestätigen die Dedifferenzierung humaner artikulä rer Chondrozyten in Monolayerkultur mit deutlicher Veränderung der Genexpression zwischen Chondrozyten und dedifferenzierten fibroblastenähnlichen Zellen. In der klinischen Anwendung der ACT zeigen die histologischen und immunhistochemischen Untersuchungen des gebildeten Reparaturgewebes die Ausbildung eines faserknorpeligen Mischgewebes, welches sich deutlich vom angrenzenden hyalinen Gelenkknorpel unterscheidet. Vor dem allgemeinen klinischen Einsatz der ACT sind weiterführende Untersuchungen über das Differenzierungsverhalten von Chondrozyten in vitro erforderlich und die Ergebnisse gut dokumentierter klinischer Studien bleiben abzuwarten. Für die erfolgreiche Behandlung von artikulären Knorpeldefekten scheint die weitere Entwicklung innovativer Behandlungskonzepte mit Kombination der Zelltransplantation und Methoden des Tissue Engineerings erforderlich. Summary: As a new biological method of cartilage repair autologous chondrocyte transplantation is recommended for the treatment of full thickness cartilage defects. The different results of the basic research, the experimental animal investigations and the clinical reports make the evaluation of the effectiveness of this method more difficult. In vitro isolated and in monolayer culture increased articular chondrocytes show within a short time period evident modifications of their morphological and functional characteristics, with the occurrence of fibroblast-like shaped cells and the loss of cartilage specific collagen synthesis. The molecularbiological analysis confirm the dedifferentiation of articular chondrocytes during monolayer culture and reveal strong modifications in the gene expression between chondrocytes and dedifferentiated fibroblastic-like cells. The histological and immunhistochemical investigation of the repair tissue after chondrocyte transplantation show clear differences to the adjacent hyaline cartilage with the formation of fibrocartilage components. Before the clinical use of autologous chondrocyte transplantation can be recommended in general resuming basic research about the biologic changes of the cultured cells and the results from well documented clinical studies remain to be waited. For a successful cartilage repair the combination of cell transplantation and methods of tissue engineering are the most promising innovations for the future. La transplantation autologue de chondrocytes est de plus en plus recommandée en tant que méthode biologique pour la réparation des défects cartilagineux articulaires circonscris. Les résultats variables en recherche fondamentale, les études expérimentales sur l'animal et les études cliniques ne permettent pas à l'heure actuelle une appréciation définitive de la valeur de cette méthode. En culture cellulaire, les cellules cartilagineuses montrent très vite des modifications morphologiques nettes, avec apparition de formes cellulaires de type fibroblastique et la perte de la synthèse de types de collagènes cartilagineux. Les études de biologie moléculaire confirment la dédifférenciation de chondrocytes articulaires humains en culture monocouche avec modification nette de l'expression génique entre chondrocytes et cellules d'allure fibroblastique dédifférenciées. En utilisation clinique de la transplantation autologue de chondrocytes les investigations histologiques et immuno-cliniques du tissu de réparation montrent le développement d'un tissu mélangé fibrocarilagineux qui se différencie nettement du cartilage hyalin voisin. Avant l'utilisation clinique généralisée du transplant autologue cartilagineux il importe de poursuivre les études sur le mode de différenciation des chondrocytes ainsi que des études cliniques bien documentées. Le développement ultérieur de concepts thérapeutiques innovants avec combinaison de transplantation cellulaire et de Tissue-Engineering sera nécessaire pour assurer le succès du traitement des défects cartilagineux articulaires. Un nuevo método biológico de reparación autólogo del cartílago mediante transplante de condrocitos es recomendado para el tratamiento de los defectos importantes y casi completos del cartílago. Los diferentes resultados sobre investigaciones básicas en animales experimentales y su resultado clínico mostraron que la evaluación acerca de la efectividad del método es más dificultosa de la prevista. In vitro el desarrollo aislado y extendido de condrocitos articulares muestra en un corto período de tiempo evidentes modificaciones en sus características morfológicas y funcionales, con la aparición de las células simil fibroblásticas formadas y la pérdida de la síntesis de colágeno específico de cartílago. El análisis molecular biológico confirma la desdiferenciación del condrocito...

  • Seroprevalence of diphtheria immunity among injured adults in Austria

    by S Marlovits, R Stocker, A Efstratiou, K Broughton, A Kaider, V Vécsei, G Wiedermann, H Kollaritsch


  • Effect on Diphtheria Immunity of Combined Tetanus and Diphtheria Booster Vaccination in Adults

    by S. Marlovits, R. Stocker, A. Efstratiou, K. Broughton, A. Kaider, V. Vécsei, H. Kollaritsch

    The effect of a single booster injection of an adult formulation of a combined diphtheria–tetanus vaccine (Td) on diphtheria-specific immunity was evaluated. The booster injection, containing 2 IU diphtheria toxoid per dose, was given as part of the surgical wound management for adults with open soft tissue injuries. Diphtheria antitoxin concentrations were determined in serum samples from 534 patients (199 women and 335 men, aged 18–70 years) using an enzyme immunoassay and a tissue culture toxin neutralization assay. Seroimmunity against diphtheria toxin was classified at three levels: susceptibility, basic protection, and full protection against the toxic manifestations of the disease. Before vaccination, 27.1% of the subjects were susceptible to diphtheria, 26.5% had basic protection, and 46.4% were fully protected. Six weeks (minimum 25 days, maximum 98 days) after a single booster injection, 89.7% of the subjects achieved full protection against diphtheria, and only 3.9% had antitoxin levels below the protective level. The median increase from the prevaccination to postvaccination antitoxin concentration was found to be 14-fold (4.4–47; quartiles Q25 to Q75). The change in antitoxin levels after revaccination was higher in older age groups (PP=0.86) nor the country of previous immunization with a different national immunization schedule (P=0.61) had a significant influence on the revaccination effect. Systemic adverse reactions were rare, and local reactions of clinical significance were reported in only 1.9% of subjects.